• ECS signs strategic distribution agreement with Nimbus Health, a leading German medicinal cannabis distributor
• Nimbus will distribute ECS-branded medicinal cannabis in Germany, with first sales targeted for April 2026
• OzSun products will be distributed nationally via Nimbus's pharmacy network

ECS Botanics Holdings Ltd (ASX: ECS), a leading medicinal cannabis company, has secured a strategic distribution partnership with Nimbus Health GmbH, one of Germany's leading cannabis distributors with national pharmacy reach. The non-exclusive partnership provides ECS with a platform to formally enter Europe's largest medicinal cannabis market under its own brands, following its EU-GMP accreditation and completion of German market entry requirements. Nimbus will take responsibility for import, warehousing, distribution and support trade-facing brand activation and pharmacy engagement. In line with ECS's successful domestic strategy, OzSun Germany will be positioned as a high-quality, value-focused brand designed to serve the budget-conscious segment of the market. This sun grown range leverages ECS's EU-GMP certified operations and organic credentials, providing a compliant and cost-effective product for patients. The launch of OzSun coincides with increased scrutiny of GMP/GDP compliance in the German market, raising the bar for fully compliant supply chains. To support further expansion in Germany, ECS will launch a curated range of ECS-grown cultivars under its exclusive Terphogz brand licence in the second half of 2026.

ECS is confident that its offer will resonate strongly in Germany, where patients and regulators are increasingly demanding reliable, affordable, compliant medicinal cannabis backed by a proven track record.